BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rosenberg ES, Rosenthal EM, Hall EW, Barker L, Hofmeister MG, Sullivan PS, Dietz P, Mermin J, Ryerson AB. Prevalence of Hepatitis C Virus Infection in US States and the District of Columbia, 2013 to 2016. JAMA Netw Open. 2018;1:e186371. [PMID: 30646319 DOI: 10.1001/jamanetworkopen.2018.6371] [Cited by in Crossref: 84] [Cited by in F6Publishing: 83] [Article Influence: 21.0] [Reference Citation Analysis]
Number Citing Articles
1 Pro G, Tompkins DA, Azari S, Zaller N. National trends in testing for hepatitis C virus in licensed opioid treatment programs: Differences by facility ownership and state medicaid expansion status. Drug Alcohol Depend 2021;228:109092. [PMID: 34571287 DOI: 10.1016/j.drugalcdep.2021.109092] [Reference Citation Analysis]
2 Wagner K, Zhong Y, Teshale E, White K, Winstanley EL, Hettema J, Thornton K, Bisztray B, Fiuty P, Page K. Hepatitis C virus infection and polysubstance use among young adult people who inject drugs in a rural county of New Mexico. Drug Alcohol Depend 2021;220:108527. [PMID: 33465605 DOI: 10.1016/j.drugalcdep.2021.108527] [Reference Citation Analysis]
3 Metsch LR, Feaster DJ, Gooden LK, Masson C, Perlman DC, Jain MK, Matheson T, Nelson CM, Jacobs P, Tross S, Haynes L, Lucas GM, Colasanti JA, Rodriguez A, Drainoni ML, Osorio G, Nijhawan AE, Jacobson JM, Sullivan M, Metzger D, Vergara-Rodriguez P, Lubelchek R, Duan R, Batycki JN, Matthews AG, Munoz F, Jelstrom E, Mandler R, Del Rio C. Care Facilitation Advances Movement Along the Hepatitis C Care Continuum for Persons With Human Immunodeficiency Virus, Hepatitis C, and Substance Use: A Randomized Clinical Trial (CTN-0064). Open Forum Infect Dis 2021;8:ofab334. [PMID: 34377726 DOI: 10.1093/ofid/ofab334] [Reference Citation Analysis]
4 Galbraith JW, Anderson ES, Hsieh YH, Franco RA, Donnelly JP, Rodgers JB, Schechter-Perkins EM, Thompson WW, Nelson NP, Rothman RE, White DAE. High Prevalence of Hepatitis C Infection Among Adult Patients at Four Urban Emergency Departments - Birmingham, Oakland, Baltimore, and Boston, 2015-2017. MMWR Morb Mortal Wkly Rep 2020;69:569-74. [PMID: 32407307 DOI: 10.15585/mmwr.mm6919a1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
5 Prabhakar V, Kwo PY. Toward Elimination of Hepatitis C Infection: How Best to Address Gaps in the Cascade of Care? Hepatol Commun 2019;3:1174-6. [PMID: 31497738 DOI: 10.1002/hep4.1403] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
6 Petrick JL, Florio AA, Loomba R, McGlynn KA. Have incidence rates of liver cancer peaked in the United States? Cancer 2020;126:3151-5. [PMID: 32294255 DOI: 10.1002/cncr.32794] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Lier AJ, Smith K, Odekon K, Bronson S, Taub E, Tharakan M, Kelly GJ, Patel P, Marcos LA. Risk Factors Associated with Linkage to Care among Suburban Hepatitis C-Positive Baby Boomers and Injection Drug Users. Infect Dis Ther 2019;8:417-28. [PMID: 31129777 DOI: 10.1007/s40121-019-0249-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Cole AM, Keppel GA, Baldwin LM, Gilles R, Holmes J, Vance C, Kriesgman B, Linares A, Hornecker J, Paddock E, Gerrish W, Alto W, Gould D, Neher J. Room for Improvement: Rates of Birth Cohort Hepatitis C Screening in Primary Care Practices-A WWAMI Region Practice and Research Network Study. J Prim Care Community Health 2019;10:2150132719884298. [PMID: 31658872 DOI: 10.1177/2150132719884298] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Ansari B, Tote KM, Rosenberg ES, Martin EG. A Rapid Review of the Impact of Systems-Level Policies and Interventions on Population-Level Outcomes Related to the Opioid Epidemic, United States and Canada, 2014-2018. Public Health Rep 2020;135:100S-27S. [PMID: 32735190 DOI: 10.1177/0033354920922975] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
10 Li W, Chang TS, Chang SZ, Chen CH, Chen MY. Challenges of transferring rural adults with chronic HCV infection for further HCV RNA confirmation and free DAAs treatment: a success story of the interdisciplinary collaboration approach. BMC Infect Dis 2020;20:737. [PMID: 33028228 DOI: 10.1186/s12879-020-05435-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Samandari T, Wiener J, Huang YA, Hoover KW, Siddiqi AE. Impact of viral suppression among persons with HIV upon estimated HIV incidence between 2010 and 2015 in the United States. PLoS One 2020;15:e0240727. [PMID: 33064746 DOI: 10.1371/journal.pone.0240727] [Reference Citation Analysis]
12 Leach M, Chapin S, Porges I, Portner S, Charest T, Downing J, Weinstein LC. Evaluation of Risk Factors for Hepatitis C Virus Infection Among Philadelphia's Shelter-Bound, Homeless Population: Data from a Student-Run Hepatitis C Virus Screening Initiative. Popul Health Manag 2021;24:448-53. [PMID: 33252303 DOI: 10.1089/pop.2020.0143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Orekondy N, Cafardi J, Kushner T, Reau N. HCV in Women and Pregnancy. Hepatology 2019;70:1836-40. [PMID: 31135999 DOI: 10.1002/hep.30791] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Hall EW, Schillie S, Vaughan AS, Jones J, Bradley H, Lopman B, Rosenberg ES, Sullivan PS. County-Level Variation in Hepatitis C Virus Mortality and Trends in the United States, 2005-2017. Hepatology 2021;74:582-90. [PMID: 33609308 DOI: 10.1002/hep.31756] [Reference Citation Analysis]
15 Jiang X, Parker RL, Vouri SM, Lo-Ciganic W, Diaby V, Henry L, Park H. Cascade of Hepatitis C Virus Care Among Patients With Substance Use Disorders. Am J Prev Med 2021:S0749-3797(21)00271-3. [PMID: 34210584 DOI: 10.1016/j.amepre.2021.04.013] [Reference Citation Analysis]
16 Lee AB, Karumberia S, Gilmore A, Williams E, Bruner N, Overton ET, Saag MS, Franco RA. Hepatitis C Among High-Risk Alabamians: Disease Burden and Screening Effectiveness. J Infect Dis 2020;222:S365-75. [PMID: 32877566 DOI: 10.1093/infdis/jiaa207] [Reference Citation Analysis]
17 Marecki JC, Belachew B, Gao J, Raney KD. RNA helicases required for viral propagation in humans. Enzymes 2021;50:335-67. [PMID: 34861942 DOI: 10.1016/bs.enz.2021.09.005] [Reference Citation Analysis]
18 Alkrekshi A, Kassem A, Park C, Tse W. Risk of Non-Hodgkin's Lymphoma in HCV Patients in the United States Between 2013 and 2020: A Population-Based Study. Clin Lymphoma Myeloma Leuk 2021:S2152-2650(21)00244-5. [PMID: 34330674 DOI: 10.1016/j.clml.2021.06.014] [Reference Citation Analysis]
19 Sullivan PS, Woodyatt C, Koski C, Pembleton E, McGuinness P, Taussig J, Ricca A, Luisi N, Mokotoff E, Benbow N, Castel AD, Do AN, Valdiserri RO, Bradley H, Jaggi C, O'Farrell D, Filipowicz R, Siegler AJ, Curran J, Sanchez TH. A Data Visualization and Dissemination Resource to Support HIV Prevention and Care at the Local Level: Analysis and Uses of the AIDSVu Public Data Resource. J Med Internet Res 2020;22:e23173. [PMID: 33095177 DOI: 10.2196/23173] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Thomas DL. State of the Hepatitis C Virus Care Cascade. Clin Liver Dis (Hoboken) 2020;16:8-11. [PMID: 32714516 DOI: 10.1002/cld.915] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Ocal S, Muir AJ. Addressing Hepatitis C in the American Incarcerated Population: Strategies for Nationwide Elimination. Curr HIV/AIDS Rep 2020;17:18-25. [PMID: 31933274 DOI: 10.1007/s11904-019-00476-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Alkrekshi A, Tamaskar I. Safety of Immune Checkpoint Inhibitors in Patients with Cancer and Hepatitis C Virus Infection. Oncologist 2021;26:e827-30. [PMID: 33655663 DOI: 10.1002/onco.13739] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Kushner T, Chappell CA, Kim AY. Testing for Hepatitis C in Pregnancy: the Time has Come for Routine Rather than Risk-based. Curr Hepatol Rep 2019;18:206-15. [PMID: 31890461 DOI: 10.1007/s11901-019-00468-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
24 Kamara MTB, Richards VL, Somboonwit C, Park H, Seneadza NAH, Zhi Z, Jayaweera D, Thomas E, Cook RL. Self-reported hepatitis C(HCV) testing among people living with human immunodeficiency virus (PLWH). Heliyon 2021;7:e07727. [PMID: 34409188 DOI: 10.1016/j.heliyon.2021.e07727] [Reference Citation Analysis]
25 Mkuu RS, Shenkman EA, Muller KE, Huo T, Salloum RG, Cabrera R, Zarrinpar A, Thomas E, Szurek SM, Nelson DR. Do patients at high risk for Hepatitis C receive recommended testing? A retrospective cohort study of statewide Medicaid claims linked with OneFlorida clinical data. Medicine 2021;100:e28316. [DOI: 10.1097/md.0000000000028316] [Reference Citation Analysis]
26 Ton M, Widener MJ, James P, VoPham T. Food Environments and Hepatocellular Carcinoma Incidence. Int J Environ Res Public Health 2021;18:5740. [PMID: 34071856 DOI: 10.3390/ijerph18115740] [Reference Citation Analysis]
27 Zou B, Yeo YH, Le MH, Henry L, Chang ET, Lok AS, Cheung R, Nguyen MH. Prevalence of Viremic Hepatitis C Virus Infection by Age, Race/Ethnicity, and Birthplace and Disease Awareness Among Viremic Persons in the United States, 1999-2016. J Infect Dis 2020;221:408-18. [PMID: 31560391 DOI: 10.1093/infdis/jiz479] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
28 Sherbuk JE, Knick TK, Canan C, Ross P, Helbert B, Cantrell ES, Cantrell CJ, Stallings R, Barron N, Jordan D, McManus KA, Dillingham R. Development of an Interdisciplinary Telehealth Model of Provider Training and Comprehensive Care for Hepatitis C and Opioid Use Disorder in a High-Burden Region. J Infect Dis 2020;222:S354-64. [PMID: 32877562 DOI: 10.1093/infdis/jiaa141] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
29 Thomas E, Cheng WH, Dylla DE, Marx SE, Carabino J, Xu Q. Awareness and Epidemiology of Chronic Hepatitis C Virus Infections in Florida. Infect Dis Ther 2021. [PMID: 34914078 DOI: 10.1007/s40121-021-00578-5] [Reference Citation Analysis]
30 Tatar M, Keeshin SW, Mailliard M, Wilson FA. Cost-effectiveness of Universal and Targeted Hepatitis C Virus Screening in the United States. JAMA Netw Open 2020;3:e2015756. [PMID: 32880650 DOI: 10.1001/jamanetworkopen.2020.15756] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
31 Crismale JF, Ahmad J. Expanding the donor pool: Hepatitis C, hepatitis B and human immunodeficiency virus-positive donors in liver transplantation. World J Gastroenterol 2019; 25(47): 6799-6812 [PMID: 31885421 DOI: 10.3748/wjg.v25.i47.6799] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
32 Cowan EA, Dinani A, Brandspiegel S, O'Brien-Lambert C, Zaheer J, Eiting E, Loo G, Calderon Y. Nontargeted Hepatitis C Screening in an Urban Emergency Department in New York City. J Emerg Med 2021;60:299-309. [PMID: 33213988 DOI: 10.1016/j.jemermed.2020.09.034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Zhou K, Terrault NA. Gaps in Viral Hepatitis Awareness in the United States in a Population-based Study. Clin Gastroenterol Hepatol 2020;18:188-195.e4. [PMID: 31173892 DOI: 10.1016/j.cgh.2019.05.047] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
34 Sullivan PS, Bradley HM, Rio CD, Rosenberg ES. The Geography of Opioid Use Disorder: A Data Triangulation Approach. Infect Dis Clin North Am 2020;34:451-64. [PMID: 32782095 DOI: 10.1016/j.idc.2020.06.006] [Reference Citation Analysis]
35 Babiker A, Hassan M, Muhammed S, Taylor G, Poonia B, Shah A, Bagchi S. Inflammatory and cardiovascular diseases biomarkers in chronic hepatitis C virus infection: A review. Clin Cardiol 2020;43:222-34. [PMID: 31785111 DOI: 10.1002/clc.23299] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
36 Ly KN, Miniño AM, Liu SJ, Roberts H, Hughes EM, Ward JW, Jiles RB. Deaths Associated With Hepatitis C Virus Infection Among Residents in 50 States and the District of Columbia, 2016-2017. Clin Infect Dis 2020;71:1149-60. [PMID: 31586173 DOI: 10.1093/cid/ciz976] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
37 Li X, Chang HH, Cheng Q, Collender PA, Li T, He J, Waller LA, Lopman BA, Remais JV. A spatial hierarchical model for integrating and bias-correcting data from passive and active disease surveillance systems. Spat Spatiotemporal Epidemiol 2020;35:100341. [PMID: 33138957 DOI: 10.1016/j.sste.2020.100341] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Parikh NS, Koh I, VanWagner LB, Elkind MSV, Zakai NA, Cushman M. Liver Fibrosis is Associated with Ischemic Stroke Risk in Women but not Men: The REGARDS Study. J Stroke Cerebrovasc Dis 2021;30:105788. [PMID: 33866274 DOI: 10.1016/j.jstrokecerebrovasdis.2021.105788] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
39 Ghany MG, Morgan TR;  AASLD-IDSA Hepatitis C Guidance Panel. Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Hepatology. 2020;71:686-721. [PMID: 31816111 DOI: 10.1002/hep.31060] [Cited by in Crossref: 145] [Cited by in F6Publishing: 133] [Article Influence: 72.5] [Reference Citation Analysis]
40 E Williams B, Nelons D, Seaman A, Witkowska M, Ronan W, Wheelock H, Zaman A, Garcia J. Life projects: the transformative potential of direct-acting antiviral treatment for hepatitis C among people who inject drugs. Int J Drug Policy 2019;72:138-45. [PMID: 30995968 DOI: 10.1016/j.drugpo.2019.03.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
41 Yakovchenko V, DeSotto K, Drainoni ML, Lukesh W, Miller DR, Park A, Shao Q, Thornton DJ, Gifford AL. Using Lean-Facilitation to Improve Quality of Hepatitis C Testing in Primary Care. J Gen Intern Med 2021;36:349-57. [PMID: 32930938 DOI: 10.1007/s11606-020-06210-5] [Reference Citation Analysis]
42 Lin YC, Chiu WN, Chang TS, Huang TJ, Chen MY. Liver Health Literacy and Health Status Among Adults With Hepatitis C: Implications for the Nursing Profession as Part of the 2030 Global Elimination Goal. J Nurs Scholarsh 2020;52:128-35. [PMID: 31750620 DOI: 10.1111/jnu.12533] [Reference Citation Analysis]
43 Reau N, Sulkowski MS, Thomas E, Sundaram V, Xu Q, Cheng WH, Marx SE, Hayes OA, Manthena SR, Chirikov V, Dylla DE, Brooks H, Carabino JM, Saab S. Epidemiology and Clinical Characteristics of Individuals with Hepatitis C Virus Infection in the United States, 2017-2019. Adv Ther 2021;38:5777-90. [PMID: 34704194 DOI: 10.1007/s12325-021-01928-y] [Reference Citation Analysis]
44 Kamali I, Barnhart DA, Nyirahabihirwe F, de la Paix Gakuru J, Uwase M, Nizeyumuremyi E, Walker S, Mazimpaka C, de Dieu Gatete J, Makuza JD, Serumondo J, Kateera F, d'Amour Ndahimana J. Initiation of hepatitis C treatment in two rural Rwandan districts: a mobile clinic approach. BMC Infect Dis 2021;21:220. [PMID: 33632165 DOI: 10.1186/s12879-021-05920-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Soliman SHA, Orlacchio A, Verginelli F. Viral Manipulation of the Host Epigenome as a Driver of Virus-Induced Oncogenesis. Microorganisms 2021;9:1179. [PMID: 34070716 DOI: 10.3390/microorganisms9061179] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Hall EW, Bradley H. Gaps in Descriptive Epidemiology and Hepatitis C Virus Modeling Research. JAMA Netw Open 2020;3:e2016120. [PMID: 32880647 DOI: 10.1001/jamanetworkopen.2020.16120] [Reference Citation Analysis]
47 Zhang G, Patel K, Moghe A, Reid A, Serper M, Calgaro L, Gibson S, Zickmund S, Shaikh O, Rogal S. Provider Perceptions of Hepatitis C Treatment Adherence and Initiation. Dig Dis Sci 2020;65:1324-33. [PMID: 31642008 DOI: 10.1007/s10620-019-05877-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
48 Nakayama JY, Ho J, Cartwright E, Simpson R, Hertzberg VS. Predictors of progression through the cascade of care to a cure for hepatitis C patients using decision trees and random forests. Comput Biol Med 2021;134:104461. [PMID: 33975209 DOI: 10.1016/j.compbiomed.2021.104461] [Reference Citation Analysis]
49 Dionne-Odom J, Cozzi GD, Franco RA, Njei B, Tita ATN. Treatment and prevention of viral hepatitis in pregnancy. Am J Obstet Gynecol 2021:S0002-9378(21)00998-4. [PMID: 34516961 DOI: 10.1016/j.ajog.2021.09.002] [Reference Citation Analysis]
50 Mirzazadeh A, Facente SN, Burk K, Kahn JG, Morris MD; End Hep C SF. Hepatitis C mortality trends in San Francisco: can we reach elimination targets? Ann Epidemiol 2021;65:59-64. [PMID: 34700016 DOI: 10.1016/j.annepidem.2021.10.004] [Reference Citation Analysis]
51 Steele WR, Dodd RY, Notari EP, Xu M, Nelson D, Kessler DA, Reik R, Williams AE, Custer B, Stramer SL; Transfusion-Transmissible Infections Monitoring System (TTIMS). Prevalence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in United States blood donations, 2015 to 2019: The Transfusion-Transmissible Infections Monitoring System (TTIMS). Transfusion 2020;60:2327-39. [PMID: 32869326 DOI: 10.1111/trf.16005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
52 Zou B, Yeo YH, Jeong D, Park H, Sheen E, Lee DH, Henry L, Garcia G, Ingelsson E, Cheung R, Nguyen MH. A Nationwide Study of Inpatient Admissions, Mortality, and Costs for Patients with Cirrhosis from 2005 to 2015 in the USA. Dig Dis Sci 2020;65:1520-8. [PMID: 31598919 DOI: 10.1007/s10620-019-05869-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
53 Dietz PM, Rose CE, McArthur D, Maenner M. National and State Estimates of Adults with Autism Spectrum Disorder. J Autism Dev Disord 2020;50:4258-66. [PMID: 32390121 DOI: 10.1007/s10803-020-04494-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 25.0] [Reference Citation Analysis]
54 Muncan B, Jordan AE, Perlman DC, Frank D, Ompad DC, Walters SM. Acceptability and Effectiveness of Hepatitis C Care at Syringe Service Programs for People Who Inject Drugs in New York City. Subst Use Misuse 2021;56:728-37. [PMID: 33682610 DOI: 10.1080/10826084.2021.1892142] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
55 Marks K, Naggie S. Management of Hepatitis C in 2019. JAMA 2019;322:355-6. [PMID: 31099822 DOI: 10.1001/jama.2019.5353] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
56 Bradley H, Rosenthal EM, Barranco MA, Udo T, Sullivan PS, Rosenberg ES. Use of Population-Based Surveys for Estimating the Population Size of Persons Who Inject Drugs in the United States. J Infect Dis 2020;222:S218-29. [PMID: 32877538 DOI: 10.1093/infdis/jiaa318] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
57 Flores BE, Fernandez AA, Wang CP, Bobadilla R, Hernandez L, Jain MK, Turner BJ. Educating Primary Care Providers and Associate Care Providers About Hepatitis C Screening of Baby Boomers: a Multi-practice Study. J Cancer Educ 2020. [PMID: 32588350 DOI: 10.1007/s13187-020-01805-2] [Reference Citation Analysis]
58 Hunt BR, Cetrone H, Sam S, Glick NR. Outcomes of a Pharmacist-Led Hepatitis C Virus Treatment Program in an Urban Safety-Net Health System, Chicago, 2017-2019. Public Health Rep 2021;:333549211015664. [PMID: 34043923 DOI: 10.1177/00333549211015664] [Reference Citation Analysis]
59 Verna EC, Schluger A, Brown RS Jr. Opioid epidemic and liver disease. JHEP Rep 2019;1:240-55. [PMID: 32039374 DOI: 10.1016/j.jhepr.2019.06.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
60 Park JS, Wong J, Cohen H. Hepatitis C virus screening of high-risk patients in a community hospital emergency department: Retrospective review of patient characteristics and future implications. PLoS One 2021;16:e0252976. [PMID: 34111200 DOI: 10.1371/journal.pone.0252976] [Reference Citation Analysis]
61 Sherbuk JE, Tabackman A, McManus KA, Kemp Knick T, Schexnayder J, Flickinger TE, Dillingham R. A qualitative study of perceived barriers to hepatitis C care among people who did not attend appointments in the non-urban US South. Harm Reduct J 2020;17:64. [PMID: 32948189 DOI: 10.1186/s12954-020-00409-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
62 Schillie S, Wester C, Osborne M, Wesolowski L, Ryerson AB. CDC Recommendations for Hepatitis C Screening Among Adults - United States, 2020. MMWR Recomm Rep. 2020;69:1-17. [PMID: 32271723 DOI: 10.15585/mmwr.rr6902a1] [Cited by in Crossref: 89] [Cited by in F6Publishing: 82] [Article Influence: 44.5] [Reference Citation Analysis]
63 Havens JR, Schaninger T, Fraser H, Lofwall M, Staton M, Young AM, Hoven A, Walsh SL, Vickerman P. Eliminating hepatitis C in a rural Appalachian county: protocol for the Kentucky Viral Hepatitis Treatment Study (KeY Treat), a phase IV, single-arm, open-label trial of sofosbuvir/velpatasvir for the treatment of hepatitis C. BMJ Open 2021;11:e041490. [PMID: 34226208 DOI: 10.1136/bmjopen-2020-041490] [Reference Citation Analysis]
64 Kushner T, Reau N. Changing epidemiology, implications, and recommendations for hepatitis C in women of childbearing age and during pregnancy. J Hepatol 2021;74:734-41. [PMID: 33248169 DOI: 10.1016/j.jhep.2020.11.027] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
65 Tabrizian P, Saberi B, Holzner ML, Rocha C, Kyung Jung Y, Myers B, Florman SS, Schwartz ME. Outcomes of transplantation for HBV- vs. HCV-related HCC: impact of DAA HCV therapy in a national analysis of >20,000 patients. HPB (Oxford) 2021:S1365-182X(21)01723-8. [PMID: 34955348 DOI: 10.1016/j.hpb.2021.11.018] [Reference Citation Analysis]
66 Hack B, Timalsina U, Tefera E, Wilkerson B, Paku E, Fernandez S, Fishbein D. Oral Prescription Opioids as a High-Risk Indicator for Hepatitis C Infection: Another Step Toward HCV Elimination. J Prim Care Community Health 2021;12:21501327211034379. [PMID: 34467805 DOI: 10.1177/21501327211034379] [Reference Citation Analysis]
67 Barocas JA, Savinkina A, Lodi S, Epstein RL, Bouton TC, Sperring H, Hsu HE, Jacobson KR, Schechter-Perkins EM, Linas BP, White LF. Projected long-term impact of the COVID-19 pandemic on hepatitis C outcomes in the United States: a modelling study. Clin Infect Dis 2021:ciab779. [PMID: 34499124 DOI: 10.1093/cid/ciab779] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
68 Bradley H, Hall EW, Rosenthal EM, Sullivan PS, Ryerson AB, Rosenberg ES. Hepatitis C Virus Prevalence in 50 U.S. States and D.C. by Sex, Birth Cohort, and Race: 2013-2016. Hepatol Commun 2020;4:355-70. [PMID: 32140654 DOI: 10.1002/hep4.1457] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
69 Bartholomew TS, Tookes HE, Bullock C, Onugha J, Forrest DW, Feaster DJ. Examining risk behavior and syringe coverage among people who inject drugs accessing a syringe services program: A latent class analysis. Int J Drug Policy 2020;78:102716. [PMID: 32146348 DOI: 10.1016/j.drugpo.2020.102716] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
70 Donroe JH, Bhatraju EP, Tsui JI, Edelman EJ. Identification and Management of Opioid Use Disorder in Primary Care: an Update. Curr Psychiatry Rep 2020;22:23. [PMID: 32285215 DOI: 10.1007/s11920-020-01149-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
71 Meyersohn NM, Mayrhofer T, Corey KE, Bittner DO, Staziaki PV, Szilveszter B, Hallett T, Lu MT, Puchner SB, Simon TG, Foldyna B, Voora D, Ginsburg GS, Douglas PS, Hoffmann U, Ferencik M. Association of Hepatic Steatosis With Major Adverse Cardiovascular Events, Independent of Coronary Artery Disease. Clin Gastroenterol Hepatol 2021;19:1480-1488.e14. [PMID: 32707340 DOI: 10.1016/j.cgh.2020.07.030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
72 Callander JK, Strohl MP, Knott PD, Park A, Seth R, Heaton CM. Hepatitis C as a Potential Risk Factor for Adverse Surgical Outcomes in Head and Neck Free Tissue Transfer Reconstruction. Facial Plast Surg Aesthet Med 2021. [PMID: 34449263 DOI: 10.1089/fpsam.2021.0082] [Reference Citation Analysis]
73 Rostata-Pesola H, Olender L, Leon N, Aytaman A, Hoffman R, Pesola GR. Hepatitis C virus screening at a Veterans Administration Hospital in New York City. J Am Assoc Nurse Pract 2020;33:646-51. [PMID: 32251032 DOI: 10.1097/JXX.0000000000000393] [Reference Citation Analysis]
74 Sperring H, Ruiz-Mercado G, Schechter-Perkins EM. Impact of the 2020 COVID-19 Pandemic on Ambulatory Hepatitis C Testing. J Prim Care Community Health. 2020;11:2150132720969554. [PMID: 33225792 DOI: 10.1177/2150132720969554] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
75 Daniel Moore J, Galbraith J, Humphries R, Havens JR. Prevalence of Hepatitis C Virus Infection Identified From Nontargeted Screening Among Adult Visitors in an Academic Appalachian Regional Emergency Department. Open Forum Infect Dis 2021;8:ofab374. [PMID: 34381848 DOI: 10.1093/ofid/ofab374] [Reference Citation Analysis]
76 Rossi RM, Wolfe C, Brokamp R, McAllister JM, Wexelblatt S, Warshak CR, Hall ES. Reported Prevalence of Maternal Hepatitis C Virus Infection in the United States. Obstet Gynecol 2020;135:387-95. [PMID: 31923064 DOI: 10.1097/AOG.0000000000003644] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
77 Ryerson AB, Schillie S, Barker LK, Kupronis BA, Wester C. Vital Signs: Newly Reported Acute and Chronic Hepatitis C Cases - United States, 2009-2018. MMWR Morb Mortal Wkly Rep 2020;69:399-404. [PMID: 32271725 DOI: 10.15585/mmwr.mm6914a2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 12.0] [Reference Citation Analysis]
78 Spaulding AC, Chen J, Mackey CA, Adee MG, Bowden CJ, Selvage WD, Thornton KA. Assessment and Comparison of Hepatitis C Viremia in the Prison Systems of New Mexico and Georgia. JAMA Netw Open 2019;2:e1910900. [PMID: 31490534 DOI: 10.1001/jamanetworkopen.2019.10900] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
79 Benitez TM, Fernando SM, Amini C, Saab S. Geographically Focused Collocated Hepatitis C Screening and Treatment in Los Angeles's Skid Row. Dig Dis Sci 2020;65:3023-31. [PMID: 31974916 DOI: 10.1007/s10620-020-06073-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
80 Kelly-Hedrick M, Gross MS. HIV-, HBV-, and HCV-Related Information on U.S. Fertility Clinic Websites: A Content Analysis. Health Equity 2020;4:345-52. [PMID: 32908955 DOI: 10.1089/heq.2019.0100] [Reference Citation Analysis]
81 Moore MS, Greene SK, Bocour A, Brown CM, Coyle JR, Kuncio D, Onofrey S, Patel MT, Winters A. Comprehensive nationwide chronic hepatitis C surveillance is necessary for accurate state-level prevalence estimates. J Viral Hepat 2019;26:1124-6. [PMID: 31087511 DOI: 10.1111/jvh.13124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
82 Liu CJ, Chen PJ. Changing epidemiology of liver disease in Asia: Dual infection of HBV and HCV. Liver Int 2021. [PMID: 34402183 DOI: 10.1111/liv.15040] [Reference Citation Analysis]
83 Walters SM, Seal DW, Stopka TJ, Murphy ME, Jenkins WD. COVID-19 and People Who Use Drugs - A Commentary. Health Behav Policy Rev 2020;7:489-97. [PMID: 33134405 DOI: 10.14485/hbpr.7.5.11] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
84 Sulkowski M, Luetkemeyer AF, Wyles DL, Martorell C, Muir A, Weisberg I, Gordon SC, McLain R, Huhn G. Impact of a digital medicine programme on hepatitis C treatment adherence and efficacy in adults at high risk for non-adherence. Aliment Pharmacol Ther 2020;51:1384-96. [PMID: 32352586 DOI: 10.1111/apt.15707] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
85 Kim NG, Kullar R, Khalil H, Saab S. Meeting the WHO hepatitis C virus elimination goal: Review of treatment in paediatrics. J Viral Hepat. 2020;27:762-769. [PMID: 32386099 DOI: 10.1111/jvh.13317] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
86 Brook DL, Hetrick AT, Chettri SR, Schalkoff CA, Sibley AL, Lancaster KE, Go VF, Miller WC, Kline DM. The Relationship Between Hepatitis C Virus Rates and Office-Based Buprenorphine Access in Ohio. Open Forum Infect Dis 2021;8:ofab242. [PMID: 34159217 DOI: 10.1093/ofid/ofab242] [Reference Citation Analysis]
87 Wainberg M, Luquez T, Koelle DM, Readhead B, Johnston C, Darvas M, Funk CC. The viral hypothesis: how herpesviruses may contribute to Alzheimer's disease. Mol Psychiatry 2021. [PMID: 33972690 DOI: 10.1038/s41380-021-01138-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
88 Vadaparampil ST, Fuzzell LN, Rathwell J, Reich RR, Shenkman E, Nelson DR, Kobetz E, Jones PD, Roetzheim R, Giuliano AR. HCV testing: Order and completion rates among baby boomers obtaining care from seven health systems in Florida, 2015-2017. Prev Med 2021;153:106222. [PMID: 32721414 DOI: 10.1016/j.ypmed.2020.106222] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
89 Bushman ET, Subramani L, Sanjanwala A, Dionne-Odom J, Franco R, Owen J, Subramaniam A. Pragmatic Experience with Risk-based versus Universal Hepatitis C Screening in Pregnancy: Detection of Infection and Postpartum Linkage to Care. Am J Perinatol 2021;38:1109-16. [PMID: 33934324 DOI: 10.1055/s-0041-1728827] [Reference Citation Analysis]
90 Abe CM, Aguwa M, Zhao M, Sullivan J, Porsa E, Nijhawan AE. Hepatitis C Virus Infection in the Dallas County Jail: Implications for Screening, Prevention, and Linkage to Care. Public Health Rep 2019;134:626-33. [PMID: 31530093 DOI: 10.1177/0033354919874081] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
91 Zeller TA, Beachler T, Diaz L, Thomas RP, Heo M, Lanzillotta-Rangeley J, Litwin AH. Attitudes toward syringe exchange programs in a rural Appalachian community. J Addict Dis 2021;:1-8. [PMID: 34550054 DOI: 10.1080/10550887.2021.1979837] [Reference Citation Analysis]